Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 82 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
811 13.3 months Ovarian Cancer 5 Chemotherapy
Université Paris Descartes France 5/2014
Treatment Details: Patients: This phase 3 study involved ovarian cancer patients who had received prior platinum-based chemotherapy and were divided into two separate treatment groups. Group A consisted of 18
 
812 13.3 months Metastatic Colorectal Cancer 5 Biologic therapy
Chemotherapy
Universitat Autònoma de Barcelona Spain 4/2015
Treatment Details: Patients: This phase 3 study involved previously treated metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A had 536 patients with an avera
 
813 13.3 months Advanced Breast Cancer 4 Chemotherapy
Taixing People's Hospital China 7/2015
Treatment Details: Patients: This study involved 52 female advanced triple-negative breast cancer patients with a median age of 53 years. Treatment: Patients received chemotherapy with oxaliplatin and S-1
 
814 13.3 months Advanced melanoma 4 Biologic therapy
Chemotherapy
Azienda Ospedaliera Universitaria Senese Italy 9/2012
Treatment Details: Patients: This phase 2 study involved 86 advanced melanoma patients. The median patient age was 54 years and 70% were male. Treatment: Patients were treated with the biologic therapy a
 
815 13.3 months Advanced NSCLC 5 Biologic therapy
Dana-Farber Cancer Institute United States 11/2013
Treatment Details: Patients: This phase 3 study involved advanced non-small-cell lung cancer patients who were separated into two different treatment groups. Group A consisted of 373 patients with a median a
 
816 13.3 months Advanced malignant pleural mesothelioma 5 Biologic therapy
Chemotherapy
Memorial Sloan Kettering Cancer Center United States 9/2014
Treatment Details: Patients: This phase 2 study involved advanced malignant pleural mesothelioma patients who had not received prior chemotherapy and who were divided into two separate treatment groups. Grou
 
817 13.3 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
St James’s University Hospital United Kingdom 1/2014
Treatment Details: Patients: This phase 2 study involved advanced non-small cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 58 patients with an average age
 
818 13.3 months Advanced or metastatic non-squamous NSCLC 5 Biologic therapy
Chemotherapy
Air Force Hospital Greece 3/2013
Treatment Details: Patients: This phase 2 study involved 48 advanced or metastatic non-squamous non-small-cell lung cancer patients who had not received prior chemotherapy. The median patient age was 61 year
 
819 13.3 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Kantonsspital Graub€unden Switzerland 11/2012
Treatment Details: Patients: This phase 2 study involved previously treated metastatic castration-resistant prostate cancer patients with a median age of 68 years. Treatment: Patients were treated with th
 
820 13.3 months Newly diagnosed Radiation
Surgery
Tohoku University School of Medicine Japan 1/2002
Treatment Details: Patients: A total of 32 patients were given this regimen. Twenty-one patients had glioblastoma multiforme and eleven patients had anaplastic astrocytoma. All patients were previously untre
 
Page 82 of 187  | Previous Page  | Next Page